(Q30987896)

28 June 2017

1 reference

title

Therapeutic management of brain metastasis (English)

1 reference

28 June 2017

1 reference

Evert C A Kaal

1

1 reference

PubMed ID

15847842

28 June 2017

Charles G J H Niël

series ordinal

2

1 reference

PubMed ID

15847842

28 June 2017

Charles J Vecht

series ordinal

3

1 reference

28 June 2017

1 May 2005

1 reference

28 June 2017

1 reference

28 June 2017

4

1 reference

28 June 2017

5

1 reference

28 June 2017

289-298

1 reference

Distribution of brain metastases

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Long-term survival in patients with brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Recursive partitioning analysis classifications I and II: applicability evaluated in a randomized trial for resected single brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Radiosurgery for brain metastases: a score index for predicting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Radiation-induced dementia in patients cured of brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Prophylactic cranial irradiation in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Cerebellar metastases: diagnostic and management considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Surgical treatment of multiple brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Prolonged survival in a subgroup of patients with brain metastases treated by gamma knife surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Repeated gamma knife radiosurgery for multiple metastatic brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Radiosurgery Followed by Planned Observation in Patients with One to Three Brain Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

The role of chemotherapy in brain metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Treatment of relapsed small-cell lung cancer--a focus on the evolving role of topotecan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Gefitinib as a first line of therapy in non-small cell lung cancer with brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Current standards of care in small-cell and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Primary chemotherapy of brain metastasis in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. a multicentre phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Temozolomide for treating brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Chemotherapy for breast cancer brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970072-7

7 January 2021

10.1016/S1474-4422(05)70072-7

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

15847842